ABBOTT INDIA
Back to Income Statement
|
ABBOTT INDIA Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹6,409 Cr | ₹5,849 Cr | ₹5,349 Cr | ₹4,913 Cr | ₹4,310 Cr |
What is the latest Revenue of ABBOTT INDIA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹6,409 Cr |
| Mar2025 | ₹5,849 Cr |
| Mar2024 | ₹5,349 Cr |
| Mar2023 | ₹4,913 Cr |
| Mar2022 | ₹4,310 Cr |
How is Revenue of ABBOTT INDIA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹6,409 Cr | 9.58 | |
| Mar2025 | ₹5,849 Cr | 9.35 | |
| Mar2024 | ₹5,349 Cr | 8.86 | |
| Mar2023 | ₹4,913 Cr | 14.00 | |
| Mar2022 | ₹4,310 Cr | - | |
Compare Revenue of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹58,766.6 Cr | -3.5% | 9% | -18.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,408.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹206,906.0 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,521.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹119,032.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -3.5% |
9% |
-18.4% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses